Im, S H <br/><br/>
Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Jun 2001 
 - 6893-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.166.11.6893  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Animals<br/>Antibody Specificity<br/>Antigens, CD<br/>Antigens, Differentiation--biosynthesis<br/>B-Lymphocytes--immunology<br/>CD40 Ligand--immunology<br/>CTLA-4 Antigen<br/>Cell Differentiation--immunology<br/>Cells, Cultured<br/>Chronic Disease<br/>Cytokines--biosynthesis<br/>Down-Regulation--immunology<br/>Female<br/>Humans<br/>Hypersensitivity, Delayed--immunology<br/>Immune Sera--administration & dosage<br/>Immunoconjugates<br/>Immunoglobulin G--biosynthesis<br/>Immunoglobulin Isotypes--biosynthesis<br/>Immunosuppressive Agents--administration & dosage<br/>Injections, Intraperitoneal<br/>Injections, Subcutaneous<br/>Lymphocyte Activation--immunology<br/>Myasthenia Gravis, Autoimmune, Experimental--immunology<br/>Rats<br/>Rats, Inbred Lew<br/>Receptors, Cholinergic--administration & dosage<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology<br/>Torpedo--immunology<br/>Up-Regulation--immunology